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Abstract
AIM: To evaluate the effectiveness of two different 
strategies using radiofrequency catheter ablation for 
redo procedures after cryoablation of atrial fibrillation.
METHODS: Thirty patients (paroxysmal atrial fibril-
lation: 22 patients, persistent atrial fibrillation: 8 pa-
tients) had to undergo a redo procedure after initially 
successful circumferential pulmonary vein (PV) isolation 
with the cryoballoon technique (Arctic Front Balloon, 
CryoCath Technologies/Medtronic). The redo ablation 
procedures were performed using a segmental ap-
proach or a circumferential ablation strategy (CARTO; 
Biosense Webster) depending on the intra-procedural 
findings. A 7-d Holter monitoring was performed at 3, 
12 and 24 mo after the ablation procedure. After dis-
charge, patients were scheduled for repeated visits at 
the arrhythmia clinic. 
RESULTS: During the redo procedure, a mean number 
of 2.9 re-conducting pulmonary veins (SD ± 1.0 PVs) 
were detected (using a circular mapping catheter). In 
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20 patients, a segmental approach was sufficient to 
eliminate the residual pulmonary vein conduction be-
cause there were only a few recovered pulmonary vein 
fibres. In the remaining 10 patients, a circumferential 
ablation strategy was used because of a complete re-
covery of the PV-LA conduction. All recovered pulmo-
nary veins could be isolated successfully again. At 2-year 
follow-up, 73.3% of all patients were free from an 
arrhythmia recurrence (22/30). There were no major 
complications. 
CONCLUSION: In patients with an initial circumferen-
tial pulmonary vein isolation using the cryoballoon tech-
nique, a repeat ablation procedure can be performed 
safely and effectively using radiofrequency catheter 
ablation. 
© 2013 Baishideng. All rights reserved.
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Core tip: We have summarized our initial experience 
with two different strategies for redo procedures using 
radiofrequency catheter ablation. Thirty patients had 
to undergo a redo procedure after initially successful 
circumferential pulmonary vein isolation with the cryo-
balloon technique. The redo ablation procedures were 
performed using a segmental approach or a circumfer-
ential ablation strategy depending on the intra-proce-
dural findings. All recovered pulmonary veins could be 
isolated successfully again. At 2-year follow-up, 73.3% 
of all patients were free from an arrhythmia recurrence.
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Catheter ablation has become the first line of therapy 
in patients with symptomatic, recurrent, drug-refractory 
atrial fibrillation (AF)
[1-7]. Cryoablation has been shown 
to be a safe and effective technique for pulmonary vein 
(PV) isolation
[1]. Although the acute success rates are 
high there is a significant arrhythmia recurrence rate after 
cryoablation during midterm follow-up
[8-14]. According 
to a recently published study, catheter ablation with the 
cryoballoon technique resulted in maintenance of sinus 
rhythm in 74% of patients with paroxysmal atrial fibril-
lation and in 42 % of patients with persistent atrial fibril-
lation [median follow-up: 12 (7-16) mo
[15-21]. Recovery 
of pulmonary vein conduction is one major reason for 
recurrences of atrial fibrillation. This is a crucial issue 
for cryoablation of AF because the cryoballoon is avail-
able with a rigid uniform design only (size: 23 or 28 mm; 
CryoCath Technologies, Quebec, Canada/Medtronic, 
Minneapolis, MN). Taking into account the high degree 
of variability of the pulmonary vein anatomy it becomes 
clear that the contact between the balloon catheter and 
the pulmonary vein ostium cannot be equally good in 
all parts of the PV ostium. Therefore, insufficient tissue 
contact of the cryoballoon seems to be a key mechanism 
for recovery of initially successfully isolated pulmonary 
veins and AF recurrences in these patients during follow-
up
[22-26]. 
There are no established strategies for redo proce-
dures after pulmonary vein isolation with the cryoballoon 
technique. From a theoretical point of view it seems to be 
reasonable to use the cryoablation technique for the redo 
procedure again because of its favourable lesion charac-
teristics
[1,22]. Such procedures can be performed either by 
using the cryoballoon technique again or by using a stan-
dard cryoablation catheter (e.g., Freezor Max; Medtronic). 
The major concern with the cryoballoon technique for 
redo procedures is that there might be insufficient tissue 
contact in the same areas as during the initial procedure 
again. This might be a risk factor for further arrhythmia 
recurrences. Alternatively, repeat ablations can be per-
formed with a segmental approach and a standard cryoab-
lation catheter (e.g., Freezor Max; Medtronic), However, a 
segmental approach using a cryoablation catheter is lim-
ited by the long duration of the cryoapplications required 
for achieving permanent lesions and by the fact that the 
position of the cryoablation catheter cannot be optimized 
during energy delivery.
Because of these limitations radiofrequency catheter 
ablation seems to be a promising approach. Therefore, the 
aim of our study was to analyse the data on pulmonary 
vein conduction recovery after pulmonary vein isolation 
with the cryoballoon technique and to evaluate two dif-
ferent strategies for redo procedures using radiofrequency 
catheter ablation. 
Depending on the extent of pulmonary vein conduc-
tion recovery we performed either a segmental pulmo-
nary vein re-isolation or an anatomically-based circum-
ferential pulmonary vein ablation in combination with a 
potential-guided segmental approach using radiofrequen-
cy energy application
[19,20].
MATERIALS AND METHODS
Patient population 
A total of 30 patients (21 men, 9 women; mean age 59.6 
± 10.0 years) with a recurrence of symptomatic atrial fi-
brillation after pulmonary vein isolation with the cryobal-
loon technique were enrolled in this study. Table 1 sum-
marizes clinical characteristics of the patients enrolled 
in our study. A repeat procedure was planned because 
of recurrent episodes of paroxysmal atrial fibrillation 
in 23 patients or persistent AF in 7 patients. The redo 
procedures were performed at a mean interval of 12.5 ± 
9.3 mo) after the initial ablation procedure. Prior to the 
initial ablation procedure paroxysmal AF had been pres-
ent in 22 patients and persistent AF had been present 
in 8 patients. The initial ablation procedures had been 
performed at our University Hospital Center (between 
November 2007 and July 2009). The initial patient co-
hort consisted of 103 patients undergoing cryoablation 
as the primary procedure. Thus, the overall arrhythmia 
recurrence rate was 29.1% after the initial cryoablation 
procedure. For the initial procedure a cryoballoon de-
vice had been used in all patients who had to undergo 
a repeat ablation procedure (23 mm: 0 patients, 28 mm: 
30 patients; CryoCath Technologies/Medtronic). In ad-
dition, a standard cryoablation catheter (Freezor Max 3; 
Medtronic) had been used in 4 patients. During the initial 
procedure a mean number of 11.6 ± 4.9 cryoapplications 
had been made using the cryoballoon device and a mean 
number of 4.0 ± 2.0 cryoapplications had been made in 
those patients in whom the standard cryoablation cath-
eter (Freezor Max; Medtronic) had been used. At the end 
of the initial ablation procedure all pulmonary veins were 
isolated successfully. There were no major complications 
during or after the initial ablation procedure. 
The repeat ablation procedures were performed at 
our University Hospital Center between March 2008 and 
November 2009. Inclusion criteria were (1) documented 
episodes of recurrent atrial fibrillation (≥ 30 s) after an 
initial ablation procedure with the cryoballoon technique 
(taking into account a blanking period of 3 mo after the 
initial ablation procedure); (2) severe symptoms despite 
antiarrhythmic drug therapy (including beta-blockers) or 
prior attemps of electrical cardioversion; (3) ability and 
willingness to give informed consent; and (4) age between 
18 and 85 years. Patients were not accepted for catheter 
ablation if one of the following conditions was present: 
severe valvular heart disease or any other concomitant 
cardiac disease requiring surgery, severely impaired left 
ventricular function (left ventricular ejection fraction < 
20%), left atrial diameter > 65 mm (parasternal long-axis 
view), left atrial thrombus, hyperthyroidism, severe renal 
insufficiency (creatinine ≥ 3 mg/dL) or another severe 
concomitant illness. 
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A three-dimensional transesophageal echocardiography 
(3-D TEE) was performed in all patients prior to the 
ablation procedure (X7-2t, 7 MHz/IE 33; Philips Health-
care). The images were available throughout the ablation 
procedure. The 3-D TEE reconstructions provided an 
excellent overview over the individual left atrial morphol-
ogy thereby facilitating the ablation procedure.
Ablation procedure 
AF ablation procedures were performed under conscious 
sedation at our institution. For the electrophysiological 
study, vascular access was obtained via both femoral veins 
and the left femoral artery. A 2500-U IV bolus of heparin 
was given shortly thereafter. First, a 6-F decapolar cath-
eter (Bard, Electrophysiology Division, Lowell, MA) was 
positioned within the coronary sinus (CS). Then, a single 
(or double) transseptal puncture was performed under 
fluoroscopic guidance. Immediately before the transsep-
tal puncture, a 5-F catheter was placed in the ascending 
aorta to mark this area and to enhance the safety of the 
procedure. In some patients no transseptal puncture was 
necessary because of a patent foramen ovale or a residual 
defect of the atrial septum. Then, a pulmonary vein an-
giography was performed. After that, all four pulmonary 
veins were reevaluated during sinus rhythm and during 
CS pacing using a Lasso-catheter (2515, 7F; Biosense 
Webster, Diamond Bar, CA). If atrial fibrillation was 
present at the beginning of the ablation procedure an 
electrical cardioversion was performed. The further strat-
egy was based on the findings documented by the circular 
mapping catheter: if there were 1-3 pulmonary veins with 
recovered PV conduction we decided to perform a re-
isolation of the recovered pulmonary veins using a seg-
mental approach (group A). If there was reconnection of 
all four pulmonary veins, an anatomically-based circum-
ferential pulmonary vein ablation in combination with 
a potential-guided segmental approach was performed 
(group B)
[20]. In addition, we classified the degree of PV 
reconnection as minor (PV spike visible on ≤ 4 bipoles 
of the Lasso catheter) or major (PV potential visible on 
≥ 5 bipoles of the Lasso catheter). 
Then, a standard irrigated-tip ablation catheter (7F; 
D-type, 3.5-mm-tip; Biosense Webster, Diamond Bar, 
CA) or a CARTO-catheter (NAVI-STAR; 7F; D-type; 
4-mm-tip; Biosense Webster) was positioned within the 
left atrium. After that, a second iv bolus of heparin was 
administered. During the procedure, the activated clotting 
time (ACT) was determined at regular intervals to ensure 
an adequate anticoagulation (ACT between 250 and 300 s). 
Then, a segmental re-isolation of the pulmonary veins 
was performed in the patients assigned to group A using 
the above-mentioned irrigated-tip ablation catheter (43°; 
25-35 W). Pulmonary vein ablation was performed during 
sinus rhythm and pacing from the coronary sinus. Pacing 
was performed from the distal CS during isolation of the 
left pulmonary veins and from the proximal CS during 
right PV ablation. If atrial fibrillation was present at the 
beginning of the ablation procedure or recurred during 
the procedure an electrical cardioversion was performed. 
Successful pulmonary vein isolation was assumed if one 
of the following criteria was met: complete disappearance 
of the pulmonary vein potential or appearance of a dis-
sociated PV potential (circumferential mapping catheter). 
In group B, a circumferential pulmonary vein ablation 
was performed in combination with a potential-guided 
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Table 1  Clinical data
Clinical data Group A  Group B  Total  P value
Patients (men/women) 20 (13/7)  10 (8/2) 30 (21/9) 0.67
Age (yr, mean ± SD) 60.0 ± 10.7  58.9 ± 9.2 59.6 ± 10.0  0.81
Cardiac disease 0.84
   None 8 6 14
   CAD 3 1 4
   DCM  2 1 3
   Valvular heart disease
1 5 1 6
   Other 2 1 3
Left ventricular ejection fraction (mean ± SD)  54.70% ± 12.00% 53.80% ± 10.30% 54.40% ± 11.20% 0.86
Previous cardiac surgery 1 1 2 1.00
Current antiarrhythmic drug therapy prior to the initial ablation procedure  3 2 5 0.94
Class Ⅰc (e.g., Flecainide, Propafenone) 6 1 7
Class Ⅲ (e.g., Amiodarone, Sotalol)  4/2 3/1 7/3
Beta-Blocker in combination with a class Ⅰc or class Ⅲ antiarrhythmic drug  2 1 3
Beta-Blocker 1 1 2
Digitalis 2 1 3
Current antiarrhythmic drug therapy prior to the repeat ablation procedure  2 1 3 0.57
Class Ic (e.g., Flecainide, Propafenone) 4 1 5
Class Ⅲ (e.g., Amiodarone, Sotalol)  4/2 2/1 6/3
Beta-Blocker in combination with a class Ⅰc or class Ⅲ antiarrhythmic drug 4 1 5
Beta-Blocker 2 0 2
Digitalis 2 4 6
1Not requiring surgery. CAD: Coronary artery disease; DCM: Dilated cardiomyopathy (left ventricular rejection fraction < 40%). Group A: Reconnection of all 
four pulmonary veins, an anatomically-based circumferential; Group B: Pulmonary vein ablation in combination with a potential-guided segmental approach.segmental approach in order to achieve complete pulmo-
nary vein isolation. Furthermore, a linear lesion was cre-
ated at the roof of the left atrium in some patients with 
persistent atrial fibrillation. In addition, catheter ablation 
of the mitral isthmus was performed in selected cases.
First, a circumferential pulmonary vein ablation was 
performed targeting the both left-sided pulmonary veins 
[43°; 30 W (posterior wall) - 35 W (anterior wall)]. In ad-
dition, a Lasso-catheter was placed in the left superior 
or left inferior pulmonary vein. After completing the 
circumferential ablation line around the left-sided PVs, 
the left superior pulmonary vein and the left inferior pul-
monary vein were reevaluated using the circular mapping 
catheter. If there was no complete PV isolation additional 
RF energy applications (43°; 25-30 W) were applied using 
a segmental approach (during sinus rhythm/CS pacing 
or recurrent AF). If the isolation of the left-sided PVs 
was assumed to be complete the right-sided PVs were 
targeted in the same way. Then, a linear lesion at the LA 
roof was created in selected patients (43°; 30-35 W). In 
a few patients an additional mitral isthmus ablation was 
performed (if there was evidence for left atrial isthmus-
dependent flutter (43°; 35-40 W). 
If atrial fibrillation was still present thereafter, an elec-
trical cardioversion was performed. Then, all four pul-
monary veins were reevaluated during sinus rhythm using 
the circumferential mapping catheter. 
If necessary additional RF applications were per-
formed using a segmental approach to achieve complete 
isolation of all four pulmonary veins. Then, the linear 
lesions at the LA roof were reevaluated during sinus 
rhythm. The ablation catheter was navigated back along 
the entire lesion to assess the presence of low-amplitude 
electrograms and the presence of double potentials or 
fractionated electrograms. If sharp high-amplitude elec-
trograms were noted, additional RF applications were 
delivered at these sites in order to achieve a complete abla-
tion line.
In addition, the linear lesions to the mitral annulus 
were reevaluated (anterior mitral isthmus line). The pres-
ence of bidirectional mitral isthmus conduction block 
was assumed if the following criteria were met: (1) pres-
ence of an unidirectional conduction block documented 
by activation mapping during pacing from the distal bi-
pole of the CS catheter (placed far within the coronary 
sinus) or the left atrial appendage; (2) documentation of 
a similar conduction time during pacing from the an-
teroseptal mitral annulus (via the ablation catheter) vs the 
distal coronary sinus or the left atrial appendage; and (3) 
a conduction time > 150 ms in both directions. 
In all patients (group A/B), a standard stomach tube 
(Flocare Nutrisoft M; Nurtica Healthcare, Châtel-St.De-
nis, Switzerland) or a special EP catheter (7 F; Osypka, 
Rheinfelden-Herten, Germany) had been introduced 
via a nasogastric route immediately before the ablation 
procedure in order to mark the esophagus. RF energy 
applications were avoided if there was a close anatomical 
relationship to the esophagus (or the power output was 
reduced as described previously
[19]). 
Finally, the completeness of the pulmonary vein isola-
tion and of all linear lesions was reassessed after a wait-
ing period of at least 20 min. Repeat selective pulmonary 
vein angiographies were performed of all targeted PVs. 
In addition, catheter ablation of the right atrial isthmus 
was performed in patients with inducible or clinically 
documented episodes of typical atrial flutter. The com-
pleteness of the right atrial isthmus lines was confirmed 
by differential pacing manoeuvres in all cases. 
For the ablation procedure, a Bard EP system (Lab-
System Pro, EP Recording System; Bard, Electrophysiol-
ogy Division, Lowell, MA) and a Stockert RF generator 
(EP-shuttle; Stockert, Freiburg, Germany) were used. 
High-resolution x-ray imaging was provided by a Philips 
device (Philips Medical Systems, Best, The Netherlands). 
Follow-up 
After hospital discharge, patients were seen regularly on 
an outpatient basis. One month after the procedure, a 
physical examination, a resting electrocardiogram (ECG) 
and a transthoracic echocardiogram were performed. The 
patients were questioned whether there was any evidence 
for an arrhythmia recurrence. In addition, a long-term 
ECG recording (24-h) was performed.
Three months after the ablation procedure, the pa-
tients were re-examined in the same way except for the 
fact that a 7-d Holter monitoring was performed and 
that each patient underwent a repeat three-dimensional 
transesophageal echocardiography to rule out a pulmo-
nary vein stenosis. Then, the patients were seen at 3-mo 
intervals if asymptomatic. If there was an arrhythmia re-
currence or other problems occurred, the further follow-
up and future strategy (e.g., electrical cardioversion, repeat 
ablation procedure) were planned on an individual basis. 
Twelve months and 24 mo after the ablation proce-
dure another 7-d Holter monitoring was performed. A 
blanking period of 3 mo was employed after ablation 
when evaluating the follow-up results. In addition, all pa-
tients were given a questionnaire 24 mo after the ablation 
procedure. The aim of this questionnaire was to evaluate 
the clinical status of the patients and to reveal whether 
there was any evidence for arrhythmia recurrences not 
detected by the long-term ECG recordings
[20]. 
Oral anticoagulation was continued for at least 3 mo 
after the procedure in all patients. During the first three 
mo after catheter ablation the patients received the same 
antiarrhythmic medication as prior to the ablation proce-
dure. If there was no evidence for an arrhythmia recur-
rence all antiarrhythmic drugs were discontinued there-
after except for beta-blockers. The beta-blocker therapy 
was continued thereafter in order to reduce the risk of 
arrhythmia recurrences during long-term follow-up and 
to achieve an adequate rate control if such arrhythmia 
recurrences occurred.
Statistical analysis
All parameters with a normal distribution are given as 
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and 25
th/75
th percentiles. χ
2 tests, t-tests, and Fischer's ex-
act test were used to compare nominal, continuous, and 
dichotomous characteristics of the two study groups at 
baseline as well as during follow-up. Significance was ac-
cepted if the P value was < 0.05. The statistical package 
of JMP (Version 3.2.6, SAS Institute, Cary, NC) was used 
for data analysis. 
RESULTS
Thirty patients were enrolled in this study between March 
2008 and November 2009. All of them had to undergo 
a repeat ablation procedure because of a recurrence of 
symptomatic atrial fibrillation after pulmonary vein isola-
tion with the cryoballoon technique. Prior to the redo 
procedure, 23 patients suffered from recurrent episodes 
of paroxysmal atrial fibrillation and 7 patients suffered 
from persistent AF. The repeat ablation procedure could 
be performed as planned in all patients. 
Procedural results
Evaluation of the pulmonary veins: During the re-
peat procedure, a mean number of 2.9 ± 1.0 PVs with 
recovered PV conduction were detected (using a circular 
mapping catheter). In all patients at least one pulmonary 
vein with recovered PV conduction was observed. In 
4 patients, there was only one pulmonary vein with re-
covered PV conduction. There were 6 patients with two 
reconnected veins and 10 patients with three reconnected 
pulmonary veins. In 10 patients, all four pulmonary veins 
showed recovered PV conduction. Seven out of 10 pa-
tients with four reconnected pulmonary veins suffered 
from persistent AF. 
Minor PV reconnection (PV spike visible on 4 ≤ bi-
poles of the Lasso catheter) was present in 77 out of 86 
reconnected veins (89.5%). Major PV reconnection (PV 
spike visible on > 4 bipoles of the Lasso catheter) was 
found in 9 out of 86 reconnected PVs (10.5%). 
Ablation strategy
After evaluating the pulmonary veins the further ablation 
strategy was planned based on the intraprocedural find-
ings. In 20 patients (with 1-3 reconnected PVs) re-isola-
tion of the recovered pulmonary veins was performed 
using a segmental approach (group A). In 10 patients, all 
four pulmonary veins showed recovered PV conduction. 
In these patients, an anatomically-based circumferential 
pulmonary vein ablation in combination with a potential-
guided segmental approach was performed (group B). In 
3 out of 10 patients in group B, an additional linear le-
sion was created at the LA roof. In 2 patients in group B, 
catheter ablation of the mitral isthmus was performed. In 
addition, catheter ablation of the right atrial isthmus was 
performed in 5 patients in group A and in 2 patients in 
group B (P = 1.0). 
The ablation procedure could be performed as 
planned in all patients. The mean procedure time was 
156 ± 41 min; group A: 147 ± 32 min; group B: 175 ± 58 
min; P = 0.07. This included all preparations and a wait-
ing period (20 min) at the end of the procedure for a final 
reevaluation of the completeness of the pulmonary vein 
isolation/linear lesions. The mean fluoroscopy dosage was 
2520 ± 2055 cGycm²; group A: 2556 ± 2178 cGycm²; 
group B: 2450 ± 1810 cGycm²; P = 0.87. 
The segmental approach could be performed success-
fully in all patients in group A. A mean number of 2.3 ± 
0.8 PVs were re-isolated per patient. At the end of the 
procedure the complete isolation of all four pulmonary 
veins could be documented in all patients using a circum-
ferential mapping catheter. 
In group B, an anatomically-based circumferential 
pulmonary vein ablation in combination with a potential-
guided segmental approach was performed successfully in 
all patients. In this group, all four pulmonary veins could 
be re-isolated successfully in all patients (documented us-
ing a circular mapping catheter). 
There were no major complications (e.g., cardiac tam-
ponade, transient ischemic attacks (TIAs) or stroke, sig-
nificant pulmonary vein stenosis (≥ 70%), periprocedural 
death) during the procedure in both groups. A transseptal 
puncture had to be performed in 17 out of 30 patients. 
In the other patients no transseptal puncture was neces-
sary because of a patent foramen ovale (7 patients) or a 
residual defect of the atrial septum (6 patients). 
Clinical outcome
The mean follow-up was 1004 ± 751 d in group A and 
821 ± 435 d in group B (P = 0.53). The mean overall 
follow-up was 940 ± 653 d. Six months after the redo 
procedure, 85.0% of the patients in group A (17/20) and 
80.0% of the patients in group B (8/10) were free from 
an arrhythmia recurrence [P = 1.0; in total: 25/30 patients 
(83.3%)]. Twelve month after the repeat ablation proce-
dure, 80.0% of all patients in group A (16/20) were still 
free from an arrhythmia recurrence compared to 70.0% 
of patients in group B (7/10; P = 0.66). Thus, the overall 
success rate was 76.7% at 1-year follow-up (no arrhyth-
mia recurrence in 23 out of 30 patients). Two years after 
the redo procedure, the overall success rate was 73.3% (no 
arrhythmia recurrence in 22 out of 30 patients). Fifteen 
out of twenty patients in group A (75.0%) and 7 out of 
10 patients in group B (70.0%) were still free from an ar-
rhythmia recurrence (P = 1.0). 
According to the analysis of the questionnaire, 24/30 
patients (80.0%) were completely asymptomatic at 24-mo 
follow-up. There were no major complications during or 
after the ablation procedures (including a follow-up dura-
tion of 24 mo). Minor complications were observed in 2 
patients (pulmonary vein stenosis < 70%: 2 patients). 
Analysing the clinical course of the patients who ex-
perienced an arrhythmia recurrence during follow-up, 7-d 
Holter monitoring revealed paroxysmal atrial fibrillation 
in 5 patients and persistent atrial fibrillation in 3 patients. 
No modification of the antiarrhythmic medication and 
no repeat ablation procedure was required in 2 patients 
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asymptomatic. In 2 patients with a symptomatic arrhyth-
mia recurrence symptoms could be controlled by modify-
ing the antiarrhythmic drug therapy. Four patients with 
symptomatic arrhythmia recurrences had to undergo a 
third ablation procedure. 
DISCUSSION 
Catheter ablation has become an important therapeutic 
option for patients with highly symptomatic and drug-
refractory atrial fibrillation. Cryoablation is a safe and ef-
fective technique for pulmonary vein isolation
[1,21], which 
is the cornerstone of catheter ablation in patients with 
paroxysmal or persistent atrial fibrillation. However, there 
is a significant arrhythmia recurrence rate after cryoabla-
tion during midterm follow-up. Catheter ablation with 
the cryoballoon technique was reported to result in main-
tenance of sinus rhythm in 74% of patients with parox-
ysmal AF and in only 42% of patients with persistent AF 
during a median follow-up of 12 (7-16) mo
[21]. Therefore, 
strategies for redo procedures are of major importance. 
However, there are no established strategies for redo pro-
cedures after PV isolation with the cryoballoon technique 
so far. Currently applied strategies for redo procedures 
are repeat ablation procedures with the cryoballoon 
technique and a segmental approach using a standard 
cryoablation catheter. Repeat ablation procedures with 
the cryoballoon technique are limited by the fact that the 
rigid design of the cryoballoon might result in insuffi-
cient tissue contact in the same areas during both proce-
dures (thereby triggering further arrhythmia recurrences). 
Repeat ablation procedures with a standard cryoablation 
catheter and a segmental approach are mainly limited by 
the long duration of (repeated) cryoapplications required 
for creating permanent lesions. 
Therefore, we have evaluated two different strate-
gies for redo procedures using radiofrequency catheter 
ablation. These ablation strategies included either a mere 
segmental pulmonary vein re-isolation or alternatively an 
anatomically-based circumferential PV ablation in com-
bination with a potential-guided segmental approach
[19,20]. 
The decision about the ablation strategy was based on 
the extent of pulmonary vein conduction recovery (doc-
umented using a circular mapping catheter at the begin-
ning of the redo procedure).
Main results
During the redo procedures, a mean number of 2.9 re-
conducting PVs (SD ± 1.0 PVs) were detected. In 20 
patients, 1-3 re-conducting PVs were detected. There 
were only 10 patients in whom all four pulmonary veins 
showed recovered PV conduction. Minor PV recon-
nection (PV spike visible on 4 ≤ bipoles of the Lasso 
catheter) was present in 77 out of 86 reconnected veins 
(89.5%). Major PV reconnection (PV spike visible on > 
4 bipoles of the Lasso catheter) was found in 9 out of 86 
reconnected PVs (10.5%).
In 20 patients (with 1-3 reconnected PVs) re-isolation 
of the recovered pulmonary veins was performed using 
a segmental approach (group A). An anatomically-based 
circumferential pulmonary vein ablation in combination 
with a potential-guided segmental approach was per-
formed in 10 patients, because recovered PV conduction 
of all four pulmonary veins was detected in these patients 
(group B). 
Two years after the repeat ablation procedure, 75.0% 
of all patients in group A (15/20) were still free from an 
arrhythmia recurrence compared to 70.0% of patients 
in group B (7/10; P = 1.0). The overall success rate was 
73.3% at 2-year follow-up. There were no major compli-
cations during or after the ablation procedures in both 
groups. 
The results of our study demonstrate that a repeat 
ablation procedure after initial PV isolation using the 
cryoballoon technique can be performed safely and ef-
fectively using radiofrequency catheter ablation. In most 
cases only a few re-conducting PV fibres were found and 
therefore, a segmental re-ablation approach seems to be 
sufficient in the majority of patients. 
There are two major advantages of radiofrequency 
catheter ablation over cryoablation for redo procedures 
after pulmonary vein isolation with the cryoballoon tech-
nique. First, due to the high degree of variability of the 
PV anatomy the contact between the cryoballoon catheter 
and the pulmonary veins cannot be equally good among 
all parts of the PV ostium. This limitation can be over-
come during the redo procedure in most cases because 
the majority of areas with insufficient tissue contact dur-
ing the initial procedure with the cryoballon technique can 
be easily reached with a standard RF ablation catheter. 
Second, the use of radiofrequency energy delivery af-
ter prior cryoablation might result in a very stable lesion 
formation. Although there are no larger studies analysing 
the histological characteristics in this setting this effect 
might have contributed to the favourable results of our 
study. Nevertheless, further studies are necessary to eval-
uate the histological changes after repeated cryoablation 
in comparison to lesions created using RF ablation for 
redo procedures after cryoablation. 
 
Limitations
This is a single centre study and, therefore, it is of mod-
erate size. However, follow-up was meticulous including 
repeat three-dimensional transesophageal echocardiog-
raphy 3 mo after the procedure to rule out a pulmonary 
vein stenosis. Furthermore, a 7-d Holter monitoring was 
performed twelve months and twenty-four months after 
the ablation procedure. The follow-up duration is longer 
than in many other studies and all patients underwent the 
final evaluation 2 years after the redo ablation procedure. 
Therefore, this study provides very reliable information 
about the long-term outcome of this patient cohort. 
Obviously, the extent of pulmonary vein conduction 
recovery after cryoablation should be evaluated in a larger 
patient cohort in a future study. A large randomized study 
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egies for redo procedures after initial pulmonary vein iso-
lation with the cryoballoon technique (i.e., repeat ablation 
with the cryoballoon technique or a segmental approach 
using a standard cryoablation catheter, a segmental pul-
monary vein re-isolation using a standard irrigated-tip RF 
ablation catheter and a circumferential ablation strategy 
using radiofrequency catheter ablation). 
In patients with an initial pulmonary vein isolation 
using the cryoballoon technique, a repeat ablation pro-
cedure can be performed safely and effectively using 
radiofrequency catheter ablation. In most cases only a 
few re-conducting PV fibres were found and therefore, a 
segmental re-ablation approach seems to be sufficient in 
the majority of patients. Alternatively, a circumferential 
approach can be performed using RF catheter ablation 
in patients with complete recovery of all four pulmonary 
veins. Obviously, the results of this study have to be con-
firmed in a larger randomized trial. 
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